Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer

被引：0

作者：

Jonathan Beesley

Hilda Pickett

Sharon Johnatty

Xiaoqing Chen

Jun Jun Li

David Rider

Michael Stutz

Diether Lambrecht

Jenny Chang-Claude

Thilo Dork

Marc Goodman

Bart Kiemmney

Elisa Bandera

Linda Kelemen

Shan Wang-Gorke

Ian Campbell

Simon Gayther

Susan Ramus

Ellen Goode

Roger Reddel

Georgia Chenevix-Trench

机构：

[1] Queensland Institute of Medical Research,Division of Genetics and Population Health

[2] Children's Medical Research Institute,Cancer Research Unit

[3] University of Sydney,Sydney Medical School

[4] Mayo Clinic College of Medicine,Department of Health Sciences Research

[5] Vesalius Research Center,Vesalius Research Center

[6] VIB,Division of Cancer Epidemiology

[7] University of Leuven,Department of Obstetrics and Gynecology

[8] German Cancer Research Center (DKFZ),Clinics of Obstetrics and Gynaecology

[9] University of Ulm,Cancer Epidemiology Program

[10] Hannover Medical School,Department of Epidemiology, Biostatistics and HTA

[11] University of Hawaii Cancer Center,Department of Urology

[12] Radboud University Nijmegen Medical Centre,The Cancer Institute of New Jersey

[13] Radboud University Nijmegen Medical Centre,Department of Population Health Research

[14] Comprehensive Cancer Center,Department of Preventive Medicine, Keck School of Medicine

[15] The Netherlands,undefined

[16] Robert Wood Johnson Medical School,undefined

[17] Alberta Health Services-Cancer Care,undefined

[18] Peter MacCallum Cancer Centre,undefined

[19] University of Southern California,undefined

来源：

Hereditary Cancer in Clinical Practice | / 10卷 / Suppl 2期

关键词：

Epithelial Ovarian Cancer; Ovarian Cancer Case; Illumina GoldenGate; Serous Epithelial Ovarian Cancer; Breast Cancer Association Consortium;

D O I：

10.1186/1897-4287-10-S2-A86

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers
Beesley, Jonathan
Pickett, Hilda A.
Johnatty, Sharon E.
Dunning, Alison M.
Chen, Xiaoqing
Li, Jun
Michailidou, Kyriaki
Lu, Yi
Rider, David N.
Palmieri, Rachel T.
Stutz, Michael D.
Lambrechts, Diether
Despierre, Evelyn
Lambrechts, Sandrina
Vergote, Ignace
Chang-Claude, Jenny
Nickels, Stefan
Vrieling, Alina
Flesch-Janys, Dieter
Wang-Gohrke, Shan
Eilber, Ursula
Bogdanova, Natalia
Antonenkova, Natalia
Runnebaum, Ingo B.
Doerk, Thilo
Goodman, Marc T.
Lurie, Galina
Wilkens, Lynne R.
Matsuno, Rayna K.
Kiemeney, Lambertus A.
Aben, Katja K. H.
Marees, Tamara
Massuger, Leon F. A. G.
Fridley, Brooke L.
Vierkant, Robert A.
Bandera, Elisa V.
Olson, Sara H.
Orlow, Irene
Rodriguez-Rodriguez, Lorna
Cook, Linda S.
Le, Nhu D.
Brooks-Wilson, Angela
Kelemen, Linda E.
Campbell, Ian
Gayther, Simon A.
Ramus, Susan J.
Gentry-Maharaj, Aleksandra
Menon, Usha
Ahmed, Shahana
Baynes, Caroline
PLOS ONE, 2011, 6 (09):
[2] Functional dissection of breast cancer risk-associated TERT promoter variants
Helbig, Sonja
Wockner, Leesa
Bouendeu, Annick
Hille-Betz, Ursula
McCue, Karen
French, Juliet D.
Edwards, Stacey L.
Pickett, Hilda A.
Reddel, Roger R.
Chenevix-Trench, Georgia
Doerk, Thilo
Beesley, Jonathan
ONCOTARGET, 2017, 8 (40) : 67203 - 67217
[3] Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women
Chan, K. Y-K
Liu, W.
Long, J-R
Yip, S-P
Chan, S-Y
Shu, X-O
Chua, D. T-T
Cheung, A. N-Y
Ching, J. C-Y
Cai, H.
Au, G. K-H
Chan, M.
Foo, W.
Ngan, H. Y-S
Gao, Y-T
Ngan, E. S-W
Garcia-Barcelo, M-M
Zheng, Wei
Khoo, U-S
JOURNAL OF MEDICAL GENETICS, 2009, 46 (01) : 32 - 39
[4] Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer
Han, Chan H.
Wei, Qingyi
Lu, Karen K.
Liu, Zhensheng
Mills, Gordon B.
Wang, Li-E
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2009, 2 (04): : 289 - 299
[5] Polymorphisms associated with breast cancer susceptibility in patients with ovarian cancer
Munoz, M. De Pedro
Tapia, E. Sanchez
Toste, R. Garcia
de Tena-Davila, Gonzalez
Sanchez, M. Doyague
Ferreira, M. Gomez
Sarmiento, R. Gonzalez
EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 592 - 593
[6] The promoter polymorphisms of survivin and ovarian cancer
Han, Chan
Wei, Qingyi
Lu, Karen
Liu, Zhensheng
Mills, Gordon
Wang, Li-E
CANCER RESEARCH, 2009, 69
[7] Genetic polymorphisms in TERT are associated with increased risk of esophageal cancer
Wu, Yifei
Yan, Mengdan
Li, Jing
Li, Jingjie
Chen, Zhengshuai
Chen, Peng
Li, Bin
Chen, Fulin
Jin, Tianbo
Chen, Chao
ONCOTARGET, 2017, 8 (06) : 10523 - 10530
[8] Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis
Li, Zhen-Yu
Dong, Ying-Li
Feng, Yun
Zhang, Zhen
Cao, Xiao-Zhong
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 1040 - 1044
[9] TERT promoter mutation in breast cancer
Kawachi, Asuka
Shimoi, Tatsunori
Yoshida, Masayuki
Kitamura, Yuka
Nishijo, Tomomi
Okuma, HItomi
Sudo, Kazuki
Shimomura, Akihiko
Noguchi, Emi
Yonemori, Kan
Shimizu, Chikako
Fujiwara, Yasuhiro
Tamura, Kenji
CANCER SCIENCE, 2018, 109 : 1008 - 1008
[10] PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer
Kim, Mi-Ja
Kim, Su Kang
Park, Hae Jeong
Chung, Dae Han
Park, Hyun-Kyung
Lee, Jong Seok
Kwon, Kee Hwan
Chung, Joo-Ho
MOLECULAR MEDICINE REPORTS, 2012, 5 (05) : 1267 - 1270

← 1 2 3 4 5 →